Lugano, Switzerland

Mathias Jud

This inventor holds 1 USPTO granted patent. Top assignee: Cerbios-Pharma Sa. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mathias Jud: Innovator in Chemical Processes

Introduction

Mathias Jud is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of chemistry, particularly in the preparation of complex organic compounds. His innovative work has led to the development of a unique process that enhances the efficiency of chemical synthesis.

Latest Patents

Mathias Jud holds a patent for a process titled "Process for the preparation of 9, 10-secocholesta-5,7,10(19)-trienes." This invention details a method for preparing 9,10-secocholesta-5,7,10(19)-trienes of a specific formula, where R¹ can be hydrogen or a hydroxy-protecting group, and R² and R³ can independently be hydrogen or OR¹. The compounds are synthesized from epoxides through a reaction with a low-valent metal reagent, preferably WCl₆. This patent showcases his expertise in organic chemistry and his ability to innovate within the field.

Career Highlights

Mathias Jud is associated with Cerbios-Pharma SA, a company known for its advancements in pharmaceutical development. His role at the company has allowed him to apply his inventive skills to real-world applications, contributing to the advancement of pharmaceutical processes and products.

Collaborations

Throughout his career, Mathias has collaborated with esteemed colleagues such as Christof Schickli and Fabrizio Marazza. These collaborations have fostered an environment of innovation and have led to further advancements in their respective fields.

Conclusion

Mathias Jud's contributions to the field of chemistry, particularly through his patented processes, highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical implications in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…